András Vida Selected Research

DNA (Deoxyribonucleic Acid)

1/2019	Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors.
1/2019	Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
1/2018	Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

András Vida Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 01/2017
2	Blister (Bulla) 11/2021 - 09/2011
2	Arthritis (Polyarthritis) 01/2019 - 01/2014
2	Rheumatoid Arthritis 01/2019 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 05/2017 - 01/2017
1	Necrosis 11/2021
1	Experimental Melanoma 01/2017
1	Metabolic Diseases (Metabolic Disease) 01/2016

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	Proteoglycans (Proteoglycan)IBA 01/2019 - 01/2014
2	EnzymesIBA 01/2018 - 01/2016
2	Melanins (Melanin)IBA 05/2017 - 01/2017
1	ChromatinIBA 11/2021
1	lysine decarboxylaseIBA 01/2019
1	CadaverineIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Amino Acid Receptors (Amino Acid Receptor)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Lithocholic AcidIBA 01/2018
1	Procainamide (Procan)FDA LinkGeneric 05/2017
1	Radioisotopes (Radionuclides)IBA 05/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2011
1	bactericidal permeability increasing proteinIBA 09/2011
1	LipopolysaccharidesIBA 09/2011

Therapy/Procedure

2	Intravenous Injections 05/2017 - 01/2017
1	Subcutaneous Injections 05/2017